基于肿瘤微环境重塑和介导T细胞靶向肿瘤的多功能纳米疫苗构建及免疫相关研究

1: B7-H6 as an efficient target for T cell-induced cytotoxicity in haematologic malignant cells. InvestigationalNew Drugs. 2021,39(1):24-33. X Sun#, J Zhao#, L Ma, X Sun, J Ge, Y Yu, J Ma*, M Zhang* 

2: T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting. Investigational New Drugs.2020,38(3):722-732. X Sun, Y Yu, L Ma, X Xue, Z Gao, J Ma*, M Zhang 

3: Bispecific anti-CD3 × anti-B7-H3 antibody mediates T-cell cytotoxic ability to human melanoma in vitro andin vivo. Investigational New Drugs. 2019,37(5):1036-104. J Ma*,T Shang, P Ma, X Sun, J Zhao, X Sun, MZhang* 

 4: Targeting bladder cancer by using activated T cells armed with bispecific antibodies. Oncology Reports .2018,39(3):1245-1252. J Ma*, J Ge, X Xue, W Xiu，P Ma, X Sun, M Zhang* 

5. 80例血液病骨髓染色体核型分析. 标记免疫分析与临床. 2018,25(10):1440-1444,1459. 马娟，高振奎， 孟倩， 李佳， 孙喜明， 赵瑾， 张曼*

科研成果获北京世纪坛医院科技进步奖两项。